Advertisement
Chinese collaborate to sequence Swedish patient genes, finding mutations new to cancer
- Insights from collaborative study of genetic material could lead to better early screening for colorectal cancer: genomics firm
Reading Time:2 minutes
Why you can trust SCMP
1
Zhang Tongin Beijing
China’s low-cost genome sequencing capabilities are being used in Europe.
Advertisement
In collaboration with Swedish institutions, Chinese researchers have analysed whole genomes and transcriptomes – which describe the set of mRNA transcripts produced in a given cell or tissue type – from 1,063 Swedish patients.
These patients suffered from colorectal cancer (CRC), the third most prevalent and the second deadliest type of tumour worldwide.
This research has identified 96 CRC-related genetic mutations, including nine previously unknown to colorectal cancer and 24 completely new to any form of cancer.
The team also built a complete model to estimate the patient’s survival time.
Advertisement
Advertisement